Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

completed375%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Combining Animal-assisted Intervention and Placebo-induced Analgesia

NCT04361968
completednot_applicable

Effects of a Multi-Ingredient Pre-Workout Supplement on Energy Expenditure During Running

NCT04352998
completednot_applicable

Attention Disengagement Training for Social Phobia

NCT00684320
terminatedphase_3

Non-invasive Repetitive Paraorbital Alternating Current Stimulation Therapy for Aphasia

NCT01277575

Clinical Trials (4)

Showing 4 of 4 trials
NCT04361968Not Applicable

Combining Animal-assisted Intervention and Placebo-induced Analgesia

Completed
NCT04352998Not Applicable

Effects of a Multi-Ingredient Pre-Workout Supplement on Energy Expenditure During Running

Completed
NCT00684320Not Applicable

Attention Disengagement Training for Social Phobia

Completed
NCT01277575Phase 3

Non-invasive Repetitive Paraorbital Alternating Current Stimulation Therapy for Aphasia

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4